Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial

Liu, XF; Dai, QL; Ye, RD; Zi, WJ; Liu, YX; Wang, HM; Zhu, WS; Ma, MM; Yin, Q; Li, M; Fan, XY; Sun, W; Han, YF; Lv, QS; Liu, R; Yang, D; Shi, ZH; Zheng, DQ; Deng, XR; Wan, Y; Wang, Z; Geng, Y; Chen, XY; Zhou, ZM; Liao, G; Jin, P; Liu, YM; Liu, XT; Zhang, M; Zhou, F; Shi, HC; Zhang, YF; Guo, FQ; Yin, CG; Niu, GZ; Zhang, M; Cai, XL; Zhu, QY; Chen, ZL; Liang, YC; Li, B; Lin, M; Wang, W; Xu, HW; Fu, XM; Liu, WH; Tian, XG; Gong, ZL; Shi, HC; Wang, CM; Lv, PH; Tao, ZH; Zhu, LF; Yang, SQ; Hu, W; Jiang, PZ; Liebeskind, DS; Pereira, VM; Leung, T; Yan, B; Davis, S; Xu, GL; Nogueira, RG

Liu, XF (corresponding author), Nanjing Univ, Med Sch, Jinling Hosp, Dept Neurol, Nanjing 210002, Peoples R China.; Nogueira, RG (corresponding author), Emory Univ, Sch Med, Grady Mem Hosp, Marcus Stroke & Neurosci Ctr, Atlanta, GA 30303 USA.

LANCET NEUROLOGY, 2020; 19 (2): 115